Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trialNina Wressnigg, Wolfgang Bender, Nicole Bézay et al.|The Lancet Infectious Diseases|2020Cited by 104
Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based VaccineAndrea Fritzer, Andreas Meinke, Beatrice M. Senn et al.|Infection and Immunity|2010Cited by 71